miR-146b correlates with increased disease activity and psoriatic tissue inflammation and promotes keratinocyte

Ling Zhang1, Shenglan Zhang2, Jianbin Wang1

  • 1Department of Dermatology, Affiliated Hospital of Hebei University of Engineering, Handan, Hebei 056002, P.R. China.

Insights

MicroRNA (miR)-146b is elevated in psoriasis, correlating with disease severity and inflammation. Overexpression of miR-146b promotes keratinocyte proliferation and inhibits apoptosis in psoriasis.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Immunology

Background:

  • Psoriasis is a chronic inflammatory skin disease.
  • MicroRNAs play crucial roles in regulating cellular processes and disease pathogenesis.
  • The specific role of microRNA (miR)-146b in psoriasis remains to be fully elucidated.

Purpose of the Study:

  • To investigate the expression levels of miR-146b in psoriatic skin tissue.
  • To determine the correlation between miR-146b expression and psoriasis disease activity and inflammation.
  • To explore the effects of miR-146b on keratinocyte proliferation and apoptosis in vitro.

Main Methods:

  • Quantification of miR-146b expression in 110 patients' psoriatic and unaffected skin using reverse transcription-quantitative PCR (RT-qPCR).
  • Assessment of disease activity using Psoriasis Area and Severity Index (PASI) scores and body surface area.
  • In vitro study involving transfection of HaCaT cells with miR-146b overexpression plasmids to analyze cell proliferation and apoptosis.

Main Results:

  • miR-146b expression was significantly increased in psoriatic tissue compared to unaffected tissue.
  • miR-146b levels showed a positive correlation with PASI scores and inflammatory markers (TNF-α, IL-6, IL-17).
  • Overexpression of miR-146b in HaCaT cells promoted proliferation and inhibited apoptosis, including TRAIL-induced apoptosis.

Conclusions:

  • miR-146b is upregulated in psoriasis and is associated with disease activity and inflammation.
  • miR-146b may contribute to the pathogenesis of psoriasis by promoting keratinocyte proliferation and inhibiting apoptosis.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K